23.

Share-based compensation expenses

 

In August and September of 2024, under its 2023 Omnibus Securities and Incentive Plan, the Company granted and issued an aggregate of approximately 0.19 million fully-vested shares of the Company’s restricted common stock to employees of the Company in exchange for their services to the Company. These shares were valued at the closing bid price of the Company’s common stock on the respective date of grant. Total compensation expenses recognized was approximately US$0.45 million for the year ended December 31, 2024.

 

In August 2024, the Company granted and issued approximately 0.18 million fully-vested and non-forfeitable shares of the Company restricted common stock to business and financial consultants in exchange for their service for a 12-month period until August 2025. Total compensation expenses amortized was approximately US$0.23 million and US$0.35 million for the years ended December 31, 2024 and 2025, respectively.

 

The table below summarized share-based compensation expenses recorded for the years ended December 31, 2025 and 2024, respectively:

 

   

Year Ended December 31,

 
   

2025

   

2024

 
   

US$(’000)

   

US$(’000)

 
                 

Sales and marketing expenses

    -       -  

General and administrative expenses

    345       684  

Research and development expenses

    -       -  

Total

    345       684  

Historical Timeline

Fiscal YearFiled
2025Mar 31, 2026Showing above
2024Apr 15, 2025
2023Jun 28, 2024
2022Apr 17, 2023
2021Apr 15, 2022
2020Apr 13, 2021
2019May 27, 2020
2018Apr 15, 2019

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.